Literature DB >> 12768005

Expression of simian immunodeficiency virus (SIV) nef in astrocytes during acute and terminal infection and requirement of nef for optimal replication of neurovirulent SIV in vitro.

Emily D Overholser1, Gary D Coleman, Jennifer L Bennett, Rebecca J Casaday, M Christine Zink, Sheila A Barber, Janice E Clements.   

Abstract

As the most numerous cells in the brain, astrocytes play a critical role in maintaining central nervous system homeostasis, and therefore, infection of astrocytes by human immunodeficiency virus (HIV) or simian immunodeficiency virus (SIV) in vivo could have important consequences for the development of HIV encephalitis. In this study, we establish that astrocytes are infected in macaques during acute SIV infection (10 days postinoculation) and during terminal infection when there is evidence of SIV-induced encephalitis. Additionally, with primary adult rhesus macaque astrocytes in vitro, we demonstrate that the macrophage-tropic, neurovirulent viruses SIV/17E-Br and SIV/17E-Fr replicate efficiently in astrocytes, while the lymphocyte-tropic, nonneurovirulent virus SIV(mac)239 open-nef does not establish productive infection. Furthermore, aminoxypentane-RANTES abolishes virus replication, suggesting that these SIV strains utilize the chemokine receptor CCR5 for entry into astrocytes. Importantly, we show that SIV Nef is required for optimal replication in primary rhesus macaque astrocytes and that normalizing input virus by particle number rather than by infectivity reveals a disparity between the ability of a Nef-deficient virus and a virus encoding a nonmyristoylated form of Nef to replicate in these central nervous system cells. Since the myristoylated form of Nef has been implicated in functions such as CD4 and major histocompatibility complex I downregulation, kinase association, and enhancement of virion infectivity, these data suggest that an as yet unidentified function of Nef may exist to facilitate SIV replication in astrocytes that may have important implications for in vivo pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12768005      PMCID: PMC156169          DOI: 10.1128/jvi.77.12.6855-6866.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  68 in total

1.  Localization of human immunodeficiency virus type 1 Gag and Env at the plasma membrane by confocal imaging.

Authors:  L Hermida-Matsumoto; M D Resh
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Simian immunodeficiency virus mac251 infection of astrocytes.

Authors:  G Guillemin; J Croitoru; R L Le Grand; M Franck-Duchenne; D Dormont; F D Boussin
Journal:  J Neurovirol       Date:  2000-06       Impact factor: 2.643

Review 3.  Controversy surrounding the existence of discrete functional classes of astrocytes in adult gray matter.

Authors:  W Walz
Journal:  Glia       Date:  2000-08       Impact factor: 7.452

Review 4.  The SIV-infected rhesus monkey model for HIV-associated dementia and implications for neurological diseases.

Authors:  D M Rausch; E A Murray; L E Eiden
Journal:  J Leukoc Biol       Date:  1999-04       Impact factor: 4.962

5.  HIV infection of fetal human astrocytes: the potential role of a receptor-mediated endocytic pathway.

Authors:  H N Hao; W D Lyman
Journal:  Brain Res       Date:  1999-03-27       Impact factor: 3.252

6.  Ability of the V3 loop of simian immunodeficiency virus to serve as a target for antibody-mediated neutralization: correlation of neutralization sensitivity, growth in macrophages, and decreased dependence on CD4.

Authors:  R E Means; T Matthews; J A Hoxie; M H Malim; T Kodama; R C Desrosiers
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

7.  LuSIV cells: a reporter cell line for the detection and quantitation of a single cycle of HIV and SIV replication.

Authors:  J W Roos; M F Maughan; Z Liao; J E Hildreth; J E Clements
Journal:  Virology       Date:  2000-08-01       Impact factor: 3.616

8.  Longitudinal analysis of behavioral, neurophysiological, viral and immunological effects of SIV infection in rhesus monkeys.

Authors:  L H Gold; H S Fox; S J Henriksen; M J Buchmeier; M R Weed; M A Taffe; S Huitrón-Resendiz; T F Horn; F E Bloom
Journal:  J Med Primatol       Date:  1998 Apr-Jun       Impact factor: 0.667

9.  A novel kinase activity associated with Nef derived from neurovirulent simian immunodeficiency virus.

Authors:  S A Barber; M T Flaherty; S M Plafker; J E Clements
Journal:  Virology       Date:  1998-11-10       Impact factor: 3.616

10.  Nucleocytoplasmic transport in human astrocytes: decreased nuclear uptake of the HIV Rev shuttle protein.

Authors:  M Neumann; E Afonina; F Ceccherini-Silberstein; S Schlicht; V Erfle; G N Pavlakis; R Brack-Werner
Journal:  J Cell Sci       Date:  2001-05       Impact factor: 5.285

View more
  31 in total

1.  Canonical type I IFN signaling in simian immunodeficiency virus-infected macrophages is disrupted by astrocyte-secreted CCL2.

Authors:  Luna Alammar Zaritsky; Lucio Gama; Janice E Clements
Journal:  J Immunol       Date:  2012-03-09       Impact factor: 5.422

2.  Astrocytes as an HIV CNS reservoir: highlights and reflections of an NIMH-sponsored symposium.

Authors:  Lena Al-Harti; Jeymohan Joseph; Avindra Nath
Journal:  J Neurovirol       Date:  2018-11-05       Impact factor: 2.643

Review 3.  Eradication of HIV from Tissue Reservoirs: Challenges for the Cure.

Authors:  Rebecca Rose; David J Nolan; Ekaterina Maidji; Cheryl A Stoddart; Elyse J Singer; Susanna L Lamers; Michael S McGrath
Journal:  AIDS Res Hum Retroviruses       Date:  2017-08-07       Impact factor: 2.205

Review 4.  An Overview of Human Immunodeficiency Virus Type 1-Associated Common Neurological Complications: Does Aging Pose a Challenge?

Authors:  Anantha Ram Nookala; Joy Mitra; Nitish S Chaudhari; Muralidhar L Hegde; Anil Kumar
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

5.  Lack of correlation between SIV-Nef evolution and rapid disease progression in morphine-dependent nonhuman primate model of AIDS.

Authors:  Richard J Noel; Alia Toro-Bahamonde; Ziomara Marrero-Otero; Suheydi Orsini; Ashish S Verma; Rakesh Kumar; Anil Kumar
Journal:  AIDS Res Hum Retroviruses       Date:  2006-08       Impact factor: 2.205

6.  Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy.

Authors:  M C Strain; S Letendre; S K Pillai; T Russell; C C Ignacio; H F Günthard; B Good; D M Smith; S M Wolinsky; M Furtado; J Marquie-Beck; J Durelle; I Grant; D D Richman; T Marcotte; J A McCutchan; R J Ellis; J K Wong
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

7.  CD4-independent entry and replication of simian immunodeficiency virus in primary rhesus macaque astrocytes are regulated by the transmembrane protein.

Authors:  Emily D Overholser; Tahar Babas; M Christine Zink; Sheila A Barber; Janice E Clements
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

8.  CCL5/RANTES gene deletion attenuates opioid-induced increases in glial CCL2/MCP-1 immunoreactivity and activation in HIV-1 Tat-exposed mice.

Authors:  Nazira El-Hage; Annadora J Bruce-Keller; Pamela E Knapp; Kurt F Hauser
Journal:  J Neuroimmune Pharmacol       Date:  2008-09-25       Impact factor: 4.147

9.  Simian fetal brain progenitor cells for studying viral neuropathogenesis.

Authors:  Naoko Iwata; Hiroaki Yoshida; Minoru Tobiume; Fumiko Ono; Takuya Shimazaki; Tetsutaro Sata; Noriko Nakajima
Journal:  J Neurovirol       Date:  2007       Impact factor: 2.643

Review 10.  HIV-1 Nef in macrophage-mediated disease pathogenesis.

Authors:  Susanna L Lamers; Gary B Fogel; Elyse J Singer; Marco Salemi; David J Nolan; Leanne C Huysentruyt; Michael S McGrath
Journal:  Int Rev Immunol       Date:  2012-12       Impact factor: 5.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.